China's pharmaceutical contractors show financial resilience against US supply chain curbs, with Genscript Biotech raising its full-year guidance for its life science service segment.
WuXi AppTec reported a 33.7 per cent rise in H1 net profit to 11.08 billion yuan, beating expectations driven by strong demand for weight-loss and diabetes drugs and US growth.
Wuxi AppTec, Asia's largest contract pharmaceutical research provider, reported H1 net income of 11.08 billion yuan, surpassing market estimates. This strong performance was driven by robust demand for weight-loss and diabetes drugs, alongside significant growth in its US business.
10x Science, a biotech startup founded in December 2025, has raised a $4.8 million seed round to build an AI platform that characterizes protein candidates for drug development. The company combines deterministic algorithms with AI agents to interpret mass spectrometry data, addressing a critical bottleneck as AI models generate more protein structure predictions. The three founders worked together in Stanford Nobel laureate Dr. Carolyn Bertozzi's lab.
Biotech startup 10x Science has secured $4.8 million in seed funding to scale its AI-driven platform. The tool automates the complex analysis of mass spectrometry data, helping pharmaceutical researchers accelerate the characterization of protein-based drug candidates.
